双特定疗法的无导航:优化管理和门诊患者的访问,重点是协调
Zahra Mahmoudjafari1, Amir Ali2, James Davis3
1From The University of Kansas Health System - Westwood Campus, Division of Hematologic Malignancies & Cellular Therapeutics, Westwood, Kansas.
Journal of the advanced practitioner in oncology
|January 13, 2025
概括
双特异性抗体 (BsAbs) 在治疗某些癌症方面表现有前途,但需要谨慎管理. 本指南为医疗保健团队提供建议,以成功实施BsAb疗法并管理潜在的毒性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 免疫治疗是一种免疫疗法.
背景情况:
- 双特异性抗体 (BsAbs) 在治疗复发性/耐火性扩散性大B细胞淋巴瘤,多发性骨髓瘤和肺癌方面越来越重要.
- 虽然在临床试验中有效,但BsAb疗法存在操作复杂性,需要多学科合作才能获得最佳的患者结果.
- 更广泛的采用需要解决财务,患者选择,护理人员和护理过渡挑战.
研究的目的:
- 为成功安装和运行双特异性抗体疗法提供全面建议.
- 为临床医生和治疗中心提供知识,以管理与BsAb相关的毒性,如细胞因子释放综合征和神经毒性.
主要方法:
- 召集了一个由学术和社区实践药剂师组成的小组,他们在临床试验和标准护理环境中使用BSAbs.
- 制定了专注于BsAb疗法的实际实施和运营挑战的建议.
主要成果:
- 确定了关键的运营挑战,包括财务考虑,患者选择,护理人员参与和护理过渡.
- 强调了管理特定毒性的重要性,例如细胞因子释放综合征 (CRS) 和免疫效应细胞相关的神经毒性综合征 (ICANS).
结论:
- 多学科合作和战略规划对于有效地将BsAb疗法纳入临床实践至关重要.
- 操作复杂性和潜在毒性的积极管理将优化BsAb治疗患者的结果.
更多相关视频
08:01Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
4.1K
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.1K
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Methods of Documentation VI: Case Management Model
559
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
559
